Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
5.02
-0.22
(-4.20%)
As of 8:01:23 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-28,684
-32,270
-26,685
-19,874
-12,901
Investing Cash Flow
17,357
19,578
-20,417
-2,324
-173
Financing Cash Flow
17,680
813
-557
105,361
4,368
End Cash Position
25,141
29,768
41,760
89,443
6,382
Capital Expenditure
-143
-422
-417
-2,324
-173
Issuance of Capital Stock
20,000
--
--
80,106
548
Issuance of Debt
255
1,292
--
30,000
3,946
Free Cash Flow
-28,827
-32,692
-27,102
-22,198
-13,074
12/31/2020 - 10/27/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2L9.SG Blueprint Medicines Corp
84.14
+1.15%
1JK.F Apellis Pharmaceuticals, Inc.
23.00
+3.56%
LT4.F Liquidia Corporation
14.14
+0.57%
CYBN.NE Cybin Inc.
10.85
+0.93%
VLA.PA Valneva SE
3.3040
+0.73%
HOTH Hoth Therapeutics, Inc.
1.1221
-9.51%
LQDA Liquidia Corporation
15.20
0.00%
INKT MiNK Therapeutics, Inc.
8.09
-0.12%
VERV Verve Therapeutics, Inc.
6.25
+2.12%
CPRX Catalyst Pharmaceuticals, Inc.
22.32
+1.01%